Literature DB >> 7690035

A novel tissue-specific calpain species expressed predominantly in the stomach comprises two alternative splicing products with and without Ca(2+)-binding domain.

H Sorimachi1, S Ishiura, K Suzuki.   

Abstract

Our previous studies have demonstrated that, in addition to the conventional mu- and m-calpains ubiquitously expressed in tissues, a muscle-specific calpain comprising a novel member of the large subunit family (p94 or nCL-1, which stands for novel Calpain Large subunit) exists in muscle cells. To clarify the physiological function of nCL-1, we screened cDNA libraries of various rat tissues for other tissue-specific calpains and, as a result, discovered a novel member of the calpain large subunit family. RNA blot analysis showed that the mRNA is expressed predominantly in the stomach. Isolated cDNA clones could be structurally divided into two groups, whose 5'-halves of about 1.1 kilobase pairs were identical, but whose 3'-halves bore no similarity at all. This suggests generation by an alternative splicing mechanism, which was proved by genomic DNA cloning. Open reading frames were found encoding 703 and 381 amino acid residues with calculated molecular masses of 79,554 and 42,591 for nCL-2 and -2', respectively. The deduced amino acid sequence of nCL-2 is very similar to those of other calpain large subunits and can be aligned without significant insertions or deletions, suggesting that nCL-2 should possess cysteine protease activity and calcium binding ability. nCL-2' is identical to the N-terminal half of nCL-2 and, thus, contains only the cysteine protease domain but not the calcium binding domain. Possible roles of the calpain family are discussed based on these findings.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690035

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Changes in intracellular calpastatin localization are mediated by reversible phosphorylation.

Authors:  M Averna; R de Tullio; M Passalacqua; F Salamino; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

2.  Capn5 is expressed in a subset of T cells and is dispensable for development.

Authors:  Tanna Franz; Lara Winckler; Thomas Boehm; T Neil Dear
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 3.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

4.  Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

Authors:  S L Meyer; D Bozyczko-Coyne; S K Mallya; C M Spais; R Bihovsky; J K Kaywooya; D M Lang; R W Scott; R Siman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

5.  Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.

Authors:  Weidong Zhang; Adebayo J Molehin; Juan U Rojo; Justin Sudduth; Pramodh K Ganapathy; Eunjee Kim; Arif J Siddiqui; Jasmin Freeborn; Souad R Sennoune; Jordan May; Samra Lazarus; Catherine Nguyen; Whitni K Redman; Gul Ahmad; Workineh Torben; Souvik Karmakar; Loc Le; Kameswara R Kottapalli; Pratibha Kottapalli; Roman F Wolf; James F Papin; David Carey; Sean A Gray; Jenn D Bergthold; Raymond T Damian; Bryan T Mayer; Florian Marks; Steven G Reed; Darrick Carter; Afzal A Siddiqui
Journal:  Ann N Y Acad Sci       Date:  2018-08       Impact factor: 5.691

6.  A Gastrointestinal Calpain Complex, G-calpain, Is a Heterodimer of CAPN8 and CAPN9 Calpain Isoforms, Which Play Catalytic and Regulatory Roles, Respectively.

Authors:  Shoji Hata; Fujiko Kitamura; Midori Yamaguchi; Hiroshi Shitara; Makoto Murakami; Hiroyuki Sorimachi
Journal:  J Biol Chem       Date:  2016-11-23       Impact factor: 5.157

7.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

8.  Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells.

Authors:  Charng-Jui Chen; Tung Nguyen; John E Shively
Journal:  Exp Cell Res       Date:  2009-11-10       Impact factor: 3.905

9.  Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense.

Authors:  Shoji Hata; Manabu Abe; Hidenori Suzuki; Fujiko Kitamura; Noriko Toyama-Sorimachi; Keiko Abe; Kenji Sakimura; Hiroyuki Sorimachi
Journal:  PLoS Genet       Date:  2010-07-29       Impact factor: 5.917

10.  Characterization of a new p94-like calpain form in human lymphocytes.

Authors:  Roberta De Tullio; Roberto Stifanese; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.